Cost: The test can be expensive and may not be covered by all insurance plans. Turnaround Time: The process can take several weeks, which may delay treatment decisions. Data Interpretation: The clinical significance of some genetic alterations may be unclear, making it difficult to determine the best course of action. Tumor Heterogeneity: Tumors can have different genetic profiles in different regions, potentially leading to incomplete results.
